This showcase will discuss targeted tailored therapy and its integral role in the innovation of patient-centered care. The delivery of targeted tailored therapies requires multidisciplinary collaborative product development and continuous evaluation from bench to bedside. Innovation through translational research models, decision-making efforts during drug development, and companion development of technology and devices are keys to the future successful delivery of targeted tailored therapies and expansion of diseases that may be treated. The showcase was developed by the Clinical Research (CR) SIAC, and presentations and attendee/speaker discussions will be used to develop future CR SIAC initiatives and collaborations.

Learning Objectives:
Describe how bioinformatics and biotechnology collaborations lead to innovation in tailored patient therapy
Describe how stakeholders in the public-private sector use collaborative models for innovations in product development and approvals of tailored therapies.